Recent Finacing
Recent Raise
Evelo Biosciences is a Cambridge-based biotech developing orally delivered monoclonal microbials (Oncobiotic therapeutics) that modulate systemic immunity via gut–host interactions to treat cancer and immuno-inflammatory and metabolic diseases.
